Skip to content

Latest News

Polycab India Q1 PAT seen up 14.5% YoY to Rs. 251.7 cr: Nirmal Bang

Polycab India Q1 PAT seen up 14.5% YoY to Rs. 251.7 cr: Nirmal Bang

Net Sales are expected to increase by 12.9 percent Y-o-Y (down 28.6 percent Q-o-Q) to Rs. 3,088.7 crore, according to Nirmal Bang.

Read More

​ Net Sales are expected to increase by 12.9 percent Y-o-Y (down 28.6 percent Q-o-Q) to Rs. 3,088.7 crore, according to Nirmal Bang. Net Sales are expected to increase by 12.9 percent Y-o-Y (down 28.6 percent Q-o-Q) to Rs. 3,088.7 crore, according to Nirmal Bang.  Moneycontrol Latest News Read More  

Net Sales are expected to increase by 12.9 percent Y-o-Y (down 28.6 percent Q-o-Q) to Rs. 3,088.7 crore, according to Nirmal Bang.

V-Guard Industries Q1 PAT seen up 15.3% YoY to Rs. 62.3 cr: Nirmal Bang

V-Guard Industries Q1 PAT seen up 15.3% YoY to Rs. 62.3 cr: Nirmal Bang

Net Sales are expected to increase by 15.4 percent Y-o-Y (up 2.2 percent Q-o-Q) to Rs. 1,165.5 crore, according to Nirmal Bang.

Read More

​ Net Sales are expected to increase by 15.4 percent Y-o-Y (up 2.2 percent Q-o-Q) to Rs. 1,165.5 crore, according to Nirmal Bang. Net Sales are expected to increase by 15.4 percent Y-o-Y (up 2.2 percent Q-o-Q) to Rs. 1,165.5 crore, according to Nirmal Bang.  Moneycontrol Latest News Read More  

Net Sales are expected to increase by 15.4 percent Y-o-Y (up 2.2 percent Q-o-Q) to Rs. 1,165.5 crore, according to Nirmal Bang.

V-Guard Industries Q1 PAT seen up 15.3% YoY to Rs. 62.3 cr: Nirmal Bang

V-Guard Industries Q1 PAT seen up 15.3% YoY to Rs. 62.3 cr: Nirmal Bang

Net Sales are expected to increase by 15.4 percent Y-o-Y (up 2.2 percent Q-o-Q) to Rs. 1,165.5 crore, according to Nirmal Bang.

Read More

​ Net Sales are expected to increase by 15.4 percent Y-o-Y (up 2.2 percent Q-o-Q) to Rs. 1,165.5 crore, according to Nirmal Bang. Net Sales are expected to increase by 15.4 percent Y-o-Y (up 2.2 percent Q-o-Q) to Rs. 1,165.5 crore, according to Nirmal Bang.  Moneycontrol Latest News Read More  

Net Sales are expected to increase by 15.4 percent Y-o-Y (up 2.2 percent Q-o-Q) to Rs. 1,165.5 crore, according to Nirmal Bang.

Dr Reddys Laboratories Q1 PAT seen up 73.7% YoY to Rs 912.4 cr: Nirmal Bang

Dr Reddys Laboratories Q1 PAT seen up 73.7% YoY to Rs 912.4 cr: Nirmal Bang

Net Sales are expected to increase by 22.3 percent Y-o-Y (down 3.1 percent Q-o-Q) to Rs 6,099.1 crore, according to Nirmal Bang.

Read More

​ Net Sales are expected to increase by 22.3 percent Y-o-Y (down 3.1 percent Q-o-Q) to Rs 6,099.1 crore, according to Nirmal Bang. Net Sales are expected to increase by 22.3 percent Y-o-Y (down 3.1 percent Q-o-Q) to Rs 6,099.1 crore, according to Nirmal Bang.  Moneycontrol Latest News Read More  

Net Sales are expected to increase by 22.3 percent Y-o-Y (down 3.1 percent Q-o-Q) to Rs 6,099.1 crore, according to Nirmal Bang.

Gland Pharma Q1 PAT may dip 14.6% YoY to Rs 195.8 cr: Nirmal Bang

Gland Pharma Q1 PAT may dip 14.6% YoY to Rs 195.8 cr: Nirmal Bang

Net Sales are expected to increase by 40.3 percent Y-o-Y (up 53.1 percent Q-o-Q) to Rs 1,210.9 crore, according to Nirmal Bang.

Read More

​ Net Sales are expected to increase by 40.3 percent Y-o-Y (up 53.1 percent Q-o-Q) to Rs 1,210.9 crore, according to Nirmal Bang. Net Sales are expected to increase by 40.3 percent Y-o-Y (up 53.1 percent Q-o-Q) to Rs 1,210.9 crore, according to Nirmal Bang.  Moneycontrol Latest News Read More  

Net Sales are expected to increase by 40.3 percent Y-o-Y (up 53.1 percent Q-o-Q) to Rs 1,210.9 crore, according to Nirmal Bang.

Indoco Remedies Q1 PAT may dip 0.1% YoY to Rs 38.5 cr: Nirmal Bang

Indoco Remedies Q1 PAT may dip 0.1% YoY to Rs 38.5 cr: Nirmal Bang

Net Sales are expected to increase by 6.8 percent Y-o-Y (up 1.8 percent Q-o-Q) to Rs 435.9 crore, according to Nirmal Bang.

Read More

​ Net Sales are expected to increase by 6.8 percent Y-o-Y (up 1.8 percent Q-o-Q) to Rs 435.9 crore, according to Nirmal Bang. Net Sales are expected to increase by 6.8 percent Y-o-Y (up 1.8 percent Q-o-Q) to Rs 435.9 crore, according to Nirmal Bang.  Moneycontrol Latest News Read More  

Net Sales are expected to increase by 6.8 percent Y-o-Y (up 1.8 percent Q-o-Q) to Rs 435.9 crore, according to Nirmal Bang.

Sun Pharma Q1 PAT seen up 8.6% YoY to Rs 2,238.8 cr: Nirmal Bang

Sun Pharma Q1 PAT seen up 8.6% YoY to Rs 2,238.8 cr: Nirmal Bang

Net Sales are expected to increase by 9.5 percent Y-o-Y (up 7.8 percent Q-o-Q) to Rs 11,784.7 crore, according to Nirmal Bang.

Read More

​ Net Sales are expected to increase by 9.5 percent Y-o-Y (up 7.8 percent Q-o-Q) to Rs 11,784.7 crore, according to Nirmal Bang. Net Sales are expected to increase by 9.5 percent Y-o-Y (up 7.8 percent Q-o-Q) to Rs 11,784.7 crore, according to Nirmal Bang.  Moneycontrol Latest News Read More  

Net Sales are expected to increase by 9.5 percent Y-o-Y (up 7.8 percent Q-o-Q) to Rs 11,784.7 crore, according to Nirmal Bang.

Natco Q1 PAT seen up 36.2% YoY to Rs 436.5 cr: Nirmal Bang

Natco Q1 PAT seen up 36.2% YoY to Rs 436.5 cr: Nirmal Bang

Net Sales are expected to increase by 35.1 percent Y-o-Y (up 33.1 percent Q-o-Q) to Rs 1,195.4 crore, according to Nirmal Bang.

Read More

​ Net Sales are expected to increase by 35.1 percent Y-o-Y (up 33.1 percent Q-o-Q) to Rs 1,195.4 crore, according to Nirmal Bang. Net Sales are expected to increase by 35.1 percent Y-o-Y (up 33.1 percent Q-o-Q) to Rs 1,195.4 crore, according to Nirmal Bang.  Moneycontrol Latest News Read More  

Net Sales are expected to increase by 35.1 percent Y-o-Y (up 33.1 percent Q-o-Q) to Rs 1,195.4 crore, according to Nirmal Bang.

Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang

Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang

Net Sales are expected to increase by 11 percent Y-o-Y (up 4.6 percent Q-o-Q) to Rs 2,604.6 crore, according to Nirmal Bang.

Read More

​ Net Sales are expected to increase by 11 percent Y-o-Y (up 4.6 percent Q-o-Q) to Rs 2,604.6 crore, according to Nirmal Bang. Net Sales are expected to increase by 11 percent Y-o-Y (up 4.6 percent Q-o-Q) to Rs 2,604.6 crore, according to Nirmal Bang.  Moneycontrol Latest News Read More  

Net Sales are expected to increase by 11 percent Y-o-Y (up 4.6 percent Q-o-Q) to Rs 2,604.6 crore, according to Nirmal Bang.

Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang

Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang

Net Sales are expected to increase by 11 percent Y-o-Y (up 4.6 percent Q-o-Q) to Rs 2,604.6 crore, according to Nirmal Bang.

Read More

​ Net Sales are expected to increase by 11 percent Y-o-Y (up 4.6 percent Q-o-Q) to Rs 2,604.6 crore, according to Nirmal Bang. Net Sales are expected to increase by 11 percent Y-o-Y (up 4.6 percent Q-o-Q) to Rs 2,604.6 crore, according to Nirmal Bang.  Moneycontrol Latest News Read More  

Net Sales are expected to increase by 11 percent Y-o-Y (up 4.6 percent Q-o-Q) to Rs 2,604.6 crore, according to Nirmal Bang.

en_USEnglish